All In Biotech

Drug Trial Radar · NCT00493987

The Role of 5-alpha Reductase in Mediating Testosterone Actions

Last checked: Nov 20, 2026Latest source record: May 13, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 184 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

184

Planned (sponsor's estimate)

Start

Nov 2002

Primary completion

Dec 2009

Study completion Mar 2010

Sponsor

Sponsor type
NIH
First posted
Jun 29, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
Male only, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

In normal men, the male hormone testosterone affects a number of things in the body including muscle function and sexual function. An enzyme in the body called 5-alpha reductase converts testosterone into another form called dihydrotestosterone (DHT) which has slightly different effects. The purpose of this study is to find out how different amounts of the two different forms of testosterone affect muscle function and sexual function in healthy young men like you. This will be done by giving the men participating in the study different combinations of hormone-related medication for 20 weeks and making measurements before, during and after the medications to look for changes in lean body tissue, muscle size, muscle strength and leg power, as well as sexual function and sexual activity in all participants.

Conditions

  • Healthy

Interventions

  • Testosterone EnanthateDrug

    testosterone ester

  • DutasterideDrug

    5 alpha-reductase inhibitor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in fat-free mass, measured by DEXA scanningTime frame: 20 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Boston University Medical Center

    Boston, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.